ENOV

Enovis Corporation Healthcare - Medical Devices Investor Relations →

YES
52.6% BELOW
↑ Moving away Was -54.0% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $47.71
14-Week RSI 33

Enovis Corporation (ENOV) closed at $22.59 as of 2026-02-02, trading 52.6% below its 200-week moving average of $47.71. This places ENOV in the extreme value zone. The stock moved further from the line this week, up from -54.0% last week. The 14-week RSI sits at 33, indicating neutral momentum.

Over the past 878 weeks of data, ENOV has crossed below its 200-week moving average 9 times. On average, these episodes lasted 56 weeks. Historically, investors who bought ENOV at the start of these episodes saw an average one-year return of +45.3%.

With a market cap of $1292 million, ENOV is a small-cap stock. The company generates a free cash flow yield of 6.9%, which is healthy. Return on equity stands at -51.0%. The stock trades at 0.6x book value.

Share count has increased 7.3% over three years, indicating dilution. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.

Over the past 16.9 years, a hypothetical investment of $100 in ENOV would have grown to $151, compared to $1070 for the S&P 500. ENOV has returned 2.5% annualized vs 15.0% for the index, underperforming the broader market over this period.

Free cash flow has been declining at a -100% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.

Growth of $100: ENOV vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After ENOV Crosses Below the Line?

Across 9 historical episodes, buying ENOV when it crossed below its 200-week moving average produced an average return of +44.1% after 12 months (median +50.0%), compared to +27.2% for the S&P 500 over the same periods. 78% of those episodes were profitable after one year. After 24 months, the average return was +49.9% vs +42.8% for the index.

Each line shows $100 invested at the moment ENOV crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Historical Touches

ENOV has crossed below its 200-week MA 9 times with an average 1-year return of +45.3% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Apr 2009Apr 20105255.2%+93.0%+98.6%
May 2010Jul 20101218.6%+69.6%+5.9%
Aug 2010Aug 201011.4%+105.0%+5.9%
Jun 2015Oct 201922758.1%-39.7%-72.1%
Mar 2020Aug 20202250.4%+63.8%-56.8%
Sep 2020Nov 2020716.4%+51.4%-57.1%
Jun 2022Jan 20233225.5%+6.5%-60.0%
Feb 2023Jun 20231819.0%+12.6%-59.5%
Jul 2023Ongoing132+54.0%Ongoing-61.9%
Average56+45.3%

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of Friday close, 2026-02-02